Mode
Text Size
Log in / Sign up

Continuous renal replacement therapy may support metabolic and circulatory stability in preterm infants with AKICRRT Treatment Shows Promise for Infants with Kidney Injury

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that CRRT may support metabolic stability in preterm infants with AKI, but evidence is limited by a small sample size.

This case report and literature review examines the management of a very low birth weight (VLBW) preterm infant experiencing acute kidney injury (AKI) in a neonatal intensive care unit. The clinical focus is on the use of continuous renal replacement therapy (CRRT) in continuous venovenous hemodiafiltration (CVVHDF) mode to manage metabolic and circulatory stability.

During the treatment period, the patient experienced an increase in urine output from 0.11 to 3.9 mL/(kg.h). Laboratory markers also showed improvement, with serum creatinine decreasing from 118.20 to 55.20 $μmol/L$ and blood urea nitrogen decreasing from 12.27 to 5.26 mmol/L. These results suggest that CRRT may assist in managing metabolic status and promoting organ function recovery.

The evidence is limited by the small sample size of a single case report, which precludes broad conclusions regarding generalizability or definitive causality. Clinical application should be interpreted with caution given the low certainty of the data. The authors suggest that early and graduated CRRT intervention may contribute to maintaining hemodynamic stability in VLBW infants with AKI.

This case report describes the treatment of a single very low birth weight (VLBW) preterm infant who suffered from acute kidney injury following perinatal asphyxia. The infant was treated in a neonatal intensive care unit using continuous renal replacement therapy (CRRT) in a specific mode called continuous venovenous hemodiafiltration.

During the treatment, several key markers showed improvement. The infant's urine output increased significantly, while levels of serum creatinine and blood urea nitrogen decreased. These changes suggest that the CRRT intervention helped manage the baby's metabolic status and circulatory stability during a critical period.

Because this is a case report involving only one patient, the results cannot be applied to all infants with kidney issues. While the treatment showed positive signs for this specific baby, more research is needed to confirm how effective it is for larger groups of infants. Talk to a neonatal specialist to understand how these treatments work for specific cases.

What this means for you:
CRRT may help stabilize kidneys in very low birth weight infants, but more large-scale studies are needed.

Common questions

What is CRRT and how does it help babies with kidney issues?

CRRT stands for continuous renal replacement therapy. In this case, it was used to manage a very low birth weight infant with acute kidney injury. The treatment helped improve the baby's urine output from 0.11 to 3.9 mL/(kg·h) and lowered levels of waste products like serum creatinine and blood urea nitrogen.

Is this treatment safe for preterm infants?

The report shows that the infant remained stable during the CRRT treatment. However, because this was a case report involving only one patient, there is not enough data to determine the overall safety or common side effects for all infants. You should consult with a neonatal specialist regarding specific risks.

How much did the baby's lab results improve during treatment?

During the study, the infant's serum creatinine decreased from 118.20 to 55.20 μmol/L and blood urea nitrogen dropped from 12.27 to 5.26 mmol/L. These results suggest that the treatment helped manage the baby's metabolic status during their stay in the intensive care unit.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
IntroductionVery low birth weight (VLBW) preterm infants are particularly vulnerable to acute kidney injury (AKI) because of immature renal function and limited physiological reserve. However, the use of continuous renal replacement therapy (CRRT) in this population remains technically demanding and clinically challenging. We report a case of successful early CRRT implementation for severe AKI secondary to perinatal asphyxia in a VLBW infant, together with a review of the relevant literature.Case presentationA female infant born at 31+6 weeks of gestation with a birth weight of 1,470 g was admitted to the neonatal intensive care unit (NICU) following severe perinatal asphyxia. Shortly after admission, she developed persistent oliguria, progressive metabolic acidosis, azotemia, and fluid overload, consistent with stage 3 AKI. Despite comprehensive supportive management, including mechanical ventilation, vasoactive support, and correction of electrolyte and acid–base disturbances, renal function and hemodynamic status continued to deteriorate. CRRT in continuous venovenous hemodiafiltration (CVVHDF) mode was initiated approximately 20 h after birth using a low initial blood flow rate and a gradual individualized ultrafiltration strategy. After 37 h of treatment, urine output increased from 0.11 to 3.9 mL/(kg·h), serum creatinine decreased from 118.20 to 55.20 μmol/L, and blood urea nitrogen decreased from 12.27 to 5.26 mmol/L, accompanied by marked improvement in metabolic status and circulatory stability. The infant was subsequently weaned from CRRT and invasive mechanical ventilation and was discharged in stable condition.ConclusionIn VLBW infants with AKI, early and graduated CRRT intervention may contribute to maintaining hemodynamic stability and facilitating organ function recovery. Meticulous peri-CRRT management is essential to ensure treatment safety.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.